Press Releases
Press Releases
More Press Releases
View Older Stories View Newer Stories-
Phio Pharmaceuticals is a Finalist for the Technology Disruptor of the Year Award
-
Magaya Promotes Kristjan Lillemets to Chief Product Officer
-
Nut Tree Capital Management and Caspian Capital Release Presentation Highlighting Why Martin Midstream Partners L.P. Unitholders Should Vote "AGAINST" Value Destructive Merger with Martin Re
-
CARFAX: Odometer Fraud Increases Nationwide to 2.14 Million Vehicles
-
M/I Homes, Inc. Announces Fourth Quarter and Year-End Earnings Webcast
-
Charter Air Direct Announces First Roundtrip Route Between Anguilla and San Juan, Puerto Rico
-
Threekit Expands AI Suite with Launch of AI Visual Configurator, the First AI-powered Product Configuration Experience
-
Live from ASH 2024 | First Dataset of Olverembatinib in Combination with Bcl-2 Inhibitor Lisaftoclax Demonstrates Potential Clinical Benefits as a Chemotherapy-Free Regimen for Children with R/R Ph+ A
-
S64 appointed to deliver cutting edge technology platform to enhance ODDO BHF’s private markets offering
-
Eneba Gets Ahead of Last-minute Holiday Rush with Instant-Delivery Digital Products
-
Vessels, undersea cables, and offshore oil installations increasingly becoming “gray zone” targets
-
Red Rover Health Earns SOC 2 Type 2 Certification
-
Holiday debt can linger until mid-2025, Achieve survey finds
-
Form 8.3 - Warpaint London Plc
-
Laser Photonics Advances PCB Marking Technology R&D for Electronics and Semiconductor Manufacturing
-
DocGo Secures Two-Year Transportation Contract Renewal with Major Tennessee Healthcare System
-
Invesco Ltd: Form 8.3 - International Paper Company; Public dealing disclosure
-
Benton Recommences Drilling at Great Burnt Copper Deposit, Extends South Pond Gold-Copper Zone to 2.3 km, and Discovers New Sulphide Zone 1 km South of South Pond
-
Mason Resources Inc. Provides Update on Its 2024 Annual General Meeting Materials amid Canada Post Strike
-
VisiRose Introduces Revolutionary Therapy for Severe Eye Infections
-
Premium Resources Continues to Intersect Significant Lengths of Mineralization at Selebi North: 16.80 Metres of 5.77% CuEq or 2.80% NiEq
-
Palisades Goldcorp & Radio Fuels Announce Business Combination to Create Leading Resource Focused Investment Issuer
-
Aero Energy and Fortune Bay to Plan Winter Drilling at the Murmac Project, Athabasca Basin, Saskatchewan
-
Invesco Ltd: Form 8.3 - Aviva PLC; Public dealing disclosure
-
Granite Creek Copper Confirms New Mineralized Zone in 2024 Drilling at Carmacks Copper-Gold-Silver Project in Yukon, Canada
-
Atlas Salt Appoints Endeavour Financial as Financial Advisor for the Project Financing of its Great Atlantic Salt Project
-
Quantum Biopharma Announces That the Safety Review Committee Recommends Commencing Dosing of Second Cohort in the Phase 1 Multiple Ascending Dose Clinical Trial for Lucid-21-302 (Lucid-MS)
-
LSEB Creative Corp Announces Approval to Trade on OTCQB Venture Marketplace
-
Vinyl Sustainability Council Presents Awards at 2024 Sustainability Summit
-
WITTENSTEIN high integrity systems (WHIS) Celebrates 25 Years of Innovation and Excellence
-
Alaska Energy Metals Extends Eureka Zone Mineralization 1.8 Kilometers to the Southeast, Nikolai Project, Alaska
-
Erdene Provides Corporate Finance Update
-
HPQ Silicon Signs Memorandum of Understanding (MOU) with Company in Northern Germany
-
LAVA Reports Third Quarter 2024 Financial Results and Announces Pipeline Reprioritization and Cash Runway Extension into 2027
-
DeFi Technologies Signs Letter of Intent to Acquire Minority Stake in Swiss Asset Management Firm Neuronomics AG
-
LOG Pharma Primary Packaging to Launch New Barrier Eco Line at Pharmapack Europe 2025
-
CME Group Announces 2025 Annual Meeting Date
-
Alphyn Granted U.S. Patent Covering First-in-Class Treatment for Atopic Dermatitis
-
VR Resources Confirms Mafic-Ultramafic Intrusion with Magmatic Sulfide in First Two Drillholes at Empire Project, Ontario
-
LINDBLAD EXPEDITIONS HOLDINGS, INC. APPOINTS NATALYA LEAHY AS CEO, RICK GOLDBERG AS CFO
-
Ampligen Co-Inventor and Former CEO Agrees to Join AIM Scientific Advisory Board if Kellner Group Nominees Are Elected
-
Endo Launches Doxycycline for Injection, USP
-
Virax Biolabs Announces Agreement with Tebubio to Expand Distribution of ImmuneSelect Across the European Union, Norway, and Switzerland
-
AllianceBernstein Launches Two Active Buffer ETFs
-
Ocular Therapeutix™ to Present at the 43rd Annual J.P. Morgan Healthcare Conference
-
Redwire Awarded $45 Million Contract from Air Force Research Laboratory to Advance Enhanced Space-Based Capabilities for the Warfighter
-
Exclusive Callan Study Examines Fees for Real Assets Funds
-
FDA Grants Breakthrough Device Designation to MeMed Severity Test for Patients with Suspected Sepsis
-
The City of Stamford WPCA Embraces More Speed, Simplicity, and Security with the All-New KUBRA EZ-PAY
-
Cybin Announces Poster Presentations at the 2024 American College of Neuropsychopharmacology Annual Meeting, Including CYB003 12-Month Efficacy Results
